Paclitaxel, Trastuzumab, and Pertuzumab in the Treatment of Metastatic HER2-Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: pertuzumab in combination with trastuzumab and paclitaxel
Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: Genentech, Inc.|University of Pennsylvania